Dunhill Financial’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.06K Buy
23
+20
+667% +$1.75K ﹤0.01% 854
2026
Q1
$278 Sell
3
-3
-50% -$275 ﹤0.01% 1202
2025
Q4
$578 Buy
6
+2
+50% +$190 ﹤0.01% 910
2025
Q3
$436 Sell
4
-3
-43% -$297 ﹤0.01% 864
2025
Q2
$639 Sell
7
-43
-86% -$4.16K ﹤0.01% 828
2025
Q1
$5.7K Sell
50
-394
-89% -$42.1K ﹤0.01% 539
2024
Q4
$46.9K Buy
444
+206
+87% +$22.1K 0.02% 188
2024
Q3
$25.7K Buy
238
+218
+1,090% +$23.8K 0.01% 235
2024
Q2
$2.13K Buy
20
+5
+33% +$589 ﹤0.01% 548
2024
Q1
$2.02K Buy
15
+3
+25% +$375 ﹤0.01% 498
2023
Q4
$1.48K Buy
+12
New +$1.34K ﹤0.01% 511

Other funds holding ZBH

Dunhill Financial's ZBH Position: Q2 2026 in Review

Dunhill Financial increased its Zimmer Biomet (ZBH) stake by 667% in Q2 2026, buying an estimated $1.75K and bringing the position to 23 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #854.

Dunhill Financial first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $46.9K in Q4 2024. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Dunhill Financial held 23 shares of Zimmer Biomet worth $2.06K as of Q2 2026.
  • Dunhill Financial bought 20 Zimmer Biomet shares in Q2 2026, an estimated $1.75K.
  • Zimmer Biomet made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #854 holding.
  • Dunhill Financial first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
  • Dunhill Financial's Zimmer Biomet position peaked at $46.9K in Q4 2024.
  • 910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.